Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion type Assertion NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_head.
- NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_provenance.
- NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion evidence source_evidence_literature NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_provenance.
- NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion SIO_000772 14578204 NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_provenance.
- NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion wasDerivedFrom befree-20150227 NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_provenance.
- NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion wasGeneratedBy ECO_0000203 NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_provenance.